Iowa audit says PBMs turned accounting moves into millions in profit
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
Supreme Court takes suo motu cognisance of access to life-saving medicines – Deccan Herald
Supreme Court takes suo motu cognisance of access to life-saving medicines Deccan HeraldSupreme Court takes suo motu cognisance of…
Sales from controversial U.S. drug discount program rose to $100B last year
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
Eli Lilly ends 340B drug discounts to some hospitals over missing claims data
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
FDA approves Colorado’s plan to import cheaper drugs from Canada
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
US Drug Costs Rise At Home, Fall Abroad as Trump Weighs Action
The prices of top prescription drugs from companies such as Amgen Inc., Pfizer Inc., and Merck & Co.,…
Ozempic Costs to Be Capped in Maryland After Drug Board Vote (1)
A Maryland board has voted to set price limits on Novo Nordisk‘s popular Ozempic weight loss drug, marking…
Capricor Therapeutics accuses Nippon Shinyaku of slow-walking Duchenne drug
Capricor Therapeutics accused Nippon Shinyaku and its U.S. subsidiary of failing to follow through on marketing plans for…
‘Netflix pricing model’ could make HIV prevention drug far more accessible
Figure 2 from the PURPOSE-1 trial changed the world. Between gray and red bars representing the study’s background…
How a 340B successor might arise from the drug price negotiations
The 340B drug discount program requires manufacturers to sell drugs to safety-net hospitals at deep discounts, so they…
Consumer group presses U.S. to authorize generic GLP-1s
Public Citizen petitioned the Trump administration to use a federal law to authorize generic competitors for GLP-1 drugs…
STAT staffers share stories they wish they had written in 2025
This year saw upheaval in all corners of health, science, and biotech. While our staff was covering all…